Thomas Weber

10PUBLICATIONS

49CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsTumour immunologyPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jul 06, 2026

Retroperitoneal bulk predicts chylothorax in follicular lymphoma-control requires systemic response.

|Dec 18, 2025

Early CAR T-cell therapy in relapsed/refractory large B-cell lymphoma is associated with lower hematotoxicity burden.

Vanja Zeremski, Enver Aydilek, Akhil Behringer

|Apr 16, 2025

Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma.

Evgenii Shumilov, Julia Katharina Scholz, Maximilian Seib

|Jul 14, 2023

Palladium and Platinum Complexes of the Antimetabolite Fludarabine with Vastly Enhanced Selectivity for Tumour over Non-Malignant Cells.

Sebastian W Schleser, Oleksandr Krytovych, Tim Ziegelmeier

|Jun 10, 2023

SAM-Competitive EZH2-Inhibitors Induce Platinum Resistance by EZH2-Independent Induction of ABC-Transporters.

Elisabeth Groß, Ralf-Axel Hilger, Franziska Lea Schümann

|Jan 25, 2023

Activated granulocytes and inflammatory cytokine signaling drive T-cell lymphoma progression and disease symptoms.

Amelie Jaeger, Sudheer Madan Mohan Gambheer, Xiaoyang Sun

Pageof 2

Frequent Collaborators

5 joint publications

Elisabeth Groß

3 joint publications

Marcus Bauer

2 joint publications

Christian R Schultze-Florey

Enver Aydilek

Vladan Vucinic

Evgenii Shumilov

Thomas Mueller

Andreas Wienke

Eva Kaebisch

Christian Koenecke

Frequent Collaborators

5 joint publications

Elisabeth Groß

3 joint publications

Marcus Bauer

2 joint publications

Christian R Schultze-Florey

2 joint publications

Enver Aydilek